Key Events This Week
27 Apr: Stock opens at Rs.979.45, gaining 1.90%
28 Apr: Intraday high of Rs.1,046.40 with a 7.51% surge
29 Apr: Minor correction, closes at Rs.1,034.10 (-1.79%)
30 Apr: Upgraded to Hold; technical momentum shifts bullish

Novartis India Ltd Upgraded to Hold on Technical Improvements and Long-Term Growth
2026-04-30 08:07:59Novartis India Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced improvement across technical indicators and long-term financial trends despite recent quarterly setbacks. The pharmaceutical company’s technical outlook has shifted to bullish, supported by strong momentum in key moving averages and MACD signals, while its valuation and quality metrics present a mixed but cautiously optimistic picture for investors.
Read full news article
Novartis India Ltd Technical Momentum Shifts Signal Bullish Outlook Amid Mixed Indicators
2026-04-30 08:00:45Novartis India Ltd has witnessed a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. Despite a day’s decline of 1.79% to close at ₹1,034.10, the stock’s underlying technical indicators suggest strengthening momentum, supported by bullish signals from MACD, moving averages, and Bollinger Bands on weekly and monthly timeframes. However, mixed readings from RSI and KST indicators highlight areas of caution for investors navigating this pharmaceutical small-cap stock.
Read full news article
Novartis India Ltd Surges 7.51% to Day's High of Rs 1046.4 — Outperforms Sector by 5.04 Percentage Points
2026-04-28 13:01:01The Sensex declined 0.47% on 28 Apr 2026, while Novartis India Ltd surged 7.51%, outperforming its Pharmaceuticals & Biotechnology sector by 5.04 percentage points. This sharp single-session gain stands out as a stock-specific event amid a broadly weak market backdrop.
Read full news article
Novartis India Ltd is Rated Sell
2026-04-21 10:10:03Novartis India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 April 2026, providing investors with the most recent and relevant data to inform their decisions.
Read full news article








